0001492648-23-000003.txt : 20231030
0001492648-23-000003.hdr.sgml : 20231030
20231030163114
ACCESSION NUMBER: 0001492648-23-000003
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20231027
FILED AS OF DATE: 20231030
DATE AS OF CHANGE: 20231030
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Woodworth Marshall H
CENTRAL INDEX KEY: 0001492648
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37809
FILM NUMBER: 231360751
MAIL ADDRESS:
STREET 1: C/O NEUROBO PHARMACEUTICALS, INC.
STREET 2: 545 CONCORD AVENUE, SUITE 210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001638287
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472389984
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 545 CONCORD AVENUE
STREET 2: SUITE 210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
BUSINESS PHONE: (857) 702-9600
MAIL ADDRESS:
STREET 1: 545 CONCORD AVENUE
STREET 2: SUITE 210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
FORMER COMPANY:
FORMER CONFORMED NAME: Gemphire Therapeutics Inc.
DATE OF NAME CHANGE: 20150331
3
1
primary_doc.xml
PRIMARY DOCUMENT
X0206
3
2023-10-27
1
0001638287
NeuroBo Pharmaceuticals, Inc.
NRBO
0001492648
Woodworth Marshall H
C/O NEUROBO PHARMACEUTICALS, INC.
545 CONCORD AVENUE, SUITE 210
CAMBRIDGE
MA
02138
0
1
0
0
Acting Chief Financial Officer
Exhibit 24, Power of Attorney, is attached.
/s/ Phillip D. Torrence, by Power of Attorney
2023-10-30
EX-24
2
poawoodworth.txt
POWER OF ATTORNEY
EXHIBIT 24
POWER OF ATTORNEY
Know all men by these presents, that the undersigned hereby constitutes and
appoints each of Samuel Katz, Phillip D. Torrence and Jeffrey Kuras,
signing singly, and with full power of substitution, his or her
true and lawful attorneyinfact to:
1. execute for and on behalf of the undersigned, with respect to the
undersigneds position as an officer and/or director of
NeuroBo Pharmaceuticals, Inc. the Company,
Form ID and Forms 3, 4 and 5 in accordance with Section 16a
of the Securities Exchange Act of 1934 and the rules thereunder;
2. do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such Form
ID or Forms 3, 4 or 5, complete and execute any amendment or amendments
thereto, and timely file such form with the United States Securities and
Exchange Commission and any stock exchange, stock market or similar
authority; and
3. take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorneyinfact, may be of benefit
to, and in the best interest of, or legally required by, the undersigned,
it being understood that the documents executed by such attorneyinfact on
behalf of the undersigned pursuant to this Power of Attorney shall be in
such form and shall contain such terms and conditions as such attorneyin
fact may approve in such attorneyinfacts discretion.
The undersigned hereby grants to each such attorneyinfact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and
powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorneyinfact, or such attorneyinfacts substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneysinfact, in serving in such capacity at the request of
the undersigned, are not assuming, nor is the Company assuming, any of the
undersigneds responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to
the undersigneds holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneysinfact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 22 day of October, 2023.
/s/ Marshall H. Woodworth